Fibrillin-1 regulates mesangial cell attachment, spreading, migration and proliferation  by Porst, M. et al.
Fibrillin-1 regulates mesangial cell attachment,
spreading, migration and proliferation
M Porst1, C Plank1, B Bieritz2, E Konik2, H Fees2, J Do¨tsch1, KF Hilgers2, DP Reinhardt3 and A Hartner1
1Klinik fu¨r Kinder und Jugendliche, Universita¨t Erlangen-Nu¨rnberg, Erlangen, Germany; 2Medizinische Klinik IV, Universita¨t Erlangen-
Nu¨rnberg, Erlangen, Germany and 3Department of Anatomy and Cell Biology and Faculty of Dentistry, McGill University, Montreal,
Quebec, Canada
The microfibrillar protein fibrillin-1 is present in many organs,
including the vasculature, eye, and dermis, and is thought to
convey structural anchorage and elastic strength. Fibrillin-1 is
also a component of the mesangial matrix. To assess the
functional relevance of fibrillin-1 for cell–matrix interactions
in the glomerulus, we studied the attachment, spreading,
migration and proliferation of mesangial cells on fibrillin-1
and the regulation of fibrillin-1 in experimental anti-Thy1.1
nephritis displaying mesangial cell migration and
proliferation in vivo. During the acute phase of experimental
Thy1.1 nephritis, glomerular fibrillin-1 messenger ribonucleic
acid expression and protein immunoreactivity were
significantly induced as compared to controls. In a
hexosaminidase-based adhesion assay, mesangial cells
showed concentration-dependent attachment to fibrillin-1,
similar to what was observed for fibronectin. The cell
attachment was Arg–Gly–Asp dependent. Further, fibrillin-1
significantly promoted spreading and focal contact formation
detected by immunostaining for vinculin. Mesangial cell
migration, assessed by a transmigration assay, and
proliferation, measured by a 5-bromo-20-deoxy-uridine
incorporation assay, were augmented by fibrillin-1. In
diabetic mice underexpressing fibrillin-1, glomerular cell
proliferation, determined by counting proliferating cell
nuclear antigen-positive cells in renal sections, was
significantly lower than in diabetic control mice. We
conclude that fibrillin-1 promotes mesangial cell attachment,
spreading, migration, and proliferation. We speculate that
fibrillin-1 may thus contribute to mesangial hypercellularity
during glomerular disease.
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Fibrillin-1 is an integral component of extracellular micro-
fibrils, which are abundantly present in elastic and nonelastic
tissues, such as the vasculature, skin, tendons, eye, and
kidney.1,2 Fibrillin-1, together with other components of the
microfibrillar and elastic fiber meshwork, contributes to the
biomechanical properties of elastic organs.2 Mutations in
the fibrillin-1 gene lead to Marfan syndrome.3,4
In the glomerulus, fibrillin-1 is abundant in the mesangial
matrix.5 Its function in this context, however, is still unclear.
Possibly, fibrillin-1 contributes to the mechanical stability
and elasticity of the glomerular capillary tuft. However, it is
also conceivable that fibrillin-1, like other extracellular matrix
molecules, has an impact on the phenotype of cells that
are in contact with this matrix component. Mesangial
cells are able to express and secrete fibrillin-1.5 Studies in
cultured fibroblasts and smooth muscle cells revealed that
fibrillin-1 contributes to the adhesion and spreading of
cells via Arg–Gly–Asp (RGD) peptide-dependent integrins.6–9
Whether or not fibrillin-1 can regulate cell migration or
proliferation has not yet been clarified. Thus, we investigated
the adhesion, spreading, migration, and proliferation of
cultivated rat mesangial cells on fibrillin-1. Moreover, we
studied expression of fibrillin-1 in the glomerulus of rats
suffering from acute Thy1.1 glomerulonephritis. This disease
is characterized by changes in the mesangial cell phenotype,
that is, a transient increase in mesangial cell migration and
proliferation.10
RESULTS
In the acute phase of experimental Thy1.1 nephritis in the rat
(day 6), an increase in matrix deposition and in the number
of mesangial cells was observed compared to vehicle-injected
controls, as described before.11 At this time point, the
expression of fibrillin-1 messenger ribonucleic acid (mRNA)
in the renal cortex and in pooled isolated glomeruli was
significantly higher in diseased animals, as determined by
real-time reverse transcriptase-polymerase chain reaction
(RT-PCR) (Figure 1a and b). Immunofluorescent stainings
for fibrillin-1 on renal cryostat sections showed a defined
mesangial staining in the glomeruli of control rats (Figure 2a)
and a more intense staining in the glomeruli at day 6 of
disease (Figure 2b). Densitometric evaluation of fibrillin-1
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staining in the glomerulus revealed significant differences
in fibrillin-1 expression in control and diseased kidneys
(Figure 2c). Tubulointerstitial fibrillin-1 staining was not
significantly increased in Thy1.1 nephritic rats compared to
controls (4.170.6% stained area per cortical view in Thy1.1
nephritic kidneys versus 3.270.6% in control kidneys, NS).
To investigate the adhesive properties of mesangial cells
on fibrillin-1, cells were seeded on the fibrillin-1 fragments
rF6H (with an RGD site) or rF16 (without an RGD site;
see Figure 3). Fibronectin (FN) was used as a positive
control. At 1 h after seeding, the percentage of adhered cells
was evaluated (Figure 4a). On rF16 in the coating concen-
trations 0.2–30 mg/ml, there was no significant adhesion of
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Figure 1 | Induction of fibrillin-1 mRNA expression in renal
cortical tissue (a) and pooled isolated glomeruli (b) during the
acute phase of Thy1.1 glomerulonephritis, as assessed by
real-time RT-PCR. Data are means7s.e.m. (*Po0.05 control
(Co) versus Thy1.1 nephritic rats, n¼ 5 per group).
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Figure 2 | Expansion of fibrillin-1 staining in the mesangial matrix
of the glomerulus. (a) Photomicrograph of a glomerulus in the
kidney of a control rat. (b) Photomicrograph of a glomerulus in the
kidney of a Thy1.1 nephritic rat. (c) Densitometric evaluation of
glomerular fibrillin-1 staining. Data are means7s.e.m. (*Po0.05
control (Co) versus Thy1.1 nephritic rats, n¼ 4 per group).
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Figure 3 | Schematic drawing of full-length fibrillin-1 and the
fibrillin-1 fragments rF16 and rF6H used in this study. rF6H
contains the only RGD site (*) in the fibrillin-1 molecule.
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Figure 4 | Adhesion of rat mesangial cells to the fibrillin-1
fragments rF6H or rF16. (a) Rat mesangial cells adhered to the
fibrillin-1 fragment containing the RGD sequence (rF6H), but not to
the fragment without the RGD sequence (rF16). Adhesion to FN was
evaluated as a positive control. (b) Mesangial cell adhesion to rF6H is
dependent on the RGD sequence. Preincubation with a blocking RGD
peptide, but not with a control RAD peptide, led to inhibition of
mesangial cell adhesion to rF6H. Results are representative for three
similar experiments. Data are means7s.d.
Kidney International (2006) 69, 450–456 451
M Porst et al.: Control of mesangial cells by fibrillin-1 o r i g i n a l a r t i c l e
cells. In contrast, on rF6H 70% of the cells adhered at a
coating concentration of 7.5 mg/ml. On FN, adhesion was
already observed at lower coating concentrations and reached
up to 90% of the cells (Figure 4a). To test if adhesion was
RGD-dependent, a blocking RGD peptide was added in
concentrations from 0.03 to 64 mM prior to the seeding of the
cells on 30 mg/ml rF6H. As a control peptide, RAD was added
in the same concentrations as the RGD peptide. In contrast
to the RAD peptide, the RGD peptide blocked adhesion of
mesangial cells on rF6H. Adhesion was completely abolished
at a concentration of 4 mM of the RGD peptide (Figure 4b).
Based on the cell attachment assays (Figure 4), for the
following experiment, coating concentrations for rF6H, FN,
and rF16 as a control were chosen from the plateau levels
(20 mg/ml). Mesangial cell spreading on the fibrillin-1
fragment rF6H 1 h after seeding was as effective as cell
spreading on the positive control FN (80% of all cells were
spread). In contrast, on rF16, only a minor portion of
adhered mesangial cells were spread (12%; Figure 5a). Similar
results were obtained counting mesangial cells containing
focal contacts (Figure 5b). About 63% of mesangial cells
showed positive staining for vinculin in focal contacts 3 h
after seeding on rF6H, which was in a range similar to
the amount of positive focal contact mesangial cells on FN
(67%). Only a small portion (4%) of cells that adhered to
rF16 contained focal contacts (Figure 5b).
Migration of mesangial cells from the extraglomerular
mesangium is known to play a role in the healing process
of experimental glomerulonephritis.12 For this reason, we
investigated the migration of mesangial cells on rF6H, which
was demonstrated to promote mesangial cell adhesion and
spreading effectively. Mesangial cell migration was followed
for 2, 4, 19, 24, and 48 h after seeding of labeled cells. Starting
at 19 h, significant mesangial cell migration was detected
on rF6H and even more pronounced on FN as compared to
bovine serum albumin (BSA) controls (Figure 6a).
Studies on mesangial cell proliferation were performed
following induction of cells with 10 mg/ml basic fibroblast
growth factor (bFGF) on rF6H or as a positive control on FN.
Proliferation of mesangial cells on rF6H was significantly
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Figure 5 | Spreading and focal contact formation of rat mesangial
cells. (a) Spreading of rat mesangial cells on the fibrillin-1 fragments
rF6H or rF16. On rF6H, mesangial cells adhered as effectively as on
the positive control matrix FN. On rF16, only a few cells showed
spreading. Inset: photomicrograph of hematoxylin—eosin-stained
spread (black arrow) or unspread (white arrowhead) mesangial cells.
This experiment is representative of three independent experiments.
(b) Focal contact formation of rat mesangial cells on the fibrillin-1
fragment rF6H or rF16. On rF6H, focal contact formation in mesangial
cells was comparable to the focal contact formation on the positive
control matrix FN. On rF16, only few attached cells showed focal
contact formation. Inset: exemplary photomicrograph of a mesangial
cell grown on rF6H immunostained for vinculin. Results are
representative of three similar experiments (*Po0.05 versus rF16 and
BSA). Data are means7s.d.
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Figure 6 | Migration and proliferation of mesangial cells.
(a) Migration of mesangial cells on rF6H or FN, both in a coating
concentration of 20 mg/ml, monitored up to 48 h. BSA coating
was used as negative control. Migration of mesangial cells was
significantly induced by rF6H as well as by FN. (b) Proliferation of
mesangial cells on rF6H or FN after stimulation with 10 ng/ml bFGF.
Proliferation of mesangial cells was significantly induced by rF6H or
FN to a similar degree. Results are representative of four similar
experiments (*Po0.05). Data are means7s.d.
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higher than on BSA, which served as a negative control
(Figure 6b). Counting of 5-bromo-20-deoxy-uridine (BrdU)-
positive cells revealed proliferation rates (48%) comparable
to those achieved by seeding cells on the positive control
matrix FN (40%). To assess a possible contribution of
the fibrillin-1 fragment rF16 to mesangial cell proliferation,
additional experiments were performed on rF6H and rF16 as
coating matrices (both mixed with 0.01% poly-L-lysine to
assure similar cell adhesion on both matrices). Mesangial cell
proliferation was induced 4073-fold on rF6H compared to
BSA coating. On rF16, proliferation was induced only 471-
fold compared to BSA. Thus, there seemed to be a very minor
contribution of rF16 to cell proliferation.
Studies with full-length fibrillin-1 were performed to
confirm that the results obtained using the fibrillin-1
fragment rF6H are comparable to full-length fibrillin-1.
Adhesion as well as proliferation of mesangial cells is induced
by full-length fibrillin-1 (Figure 7a and b).
To study the contribution of fibrillin-1 to cell proliferation
in vivo, we utilized mice with a mutation leading to a five-
fold underexpression of fibrillin-1.13 The Thy1.1 model of
glomerulonephritis cannot be induced in mice, because
mouse mesangial cells lack the Thy1.1 antigen. For this
reason, we applied another model known for induction of
mesangial cell proliferation: the streptozotocin (STZ) model
of diabetic renal hyperfiltration.14 In diabetic mice under-
expressing fibrillin-1, no induction of glomerular cell
proliferation was observed, while in diabetic wild-type
(WT) mice the number of proliferating glomerular cells
was significantly higher than in nondiabetic controls
(Figure 8).
DISCUSSION
In this study, we showed that mesangial cells in vitro adhere
to and spread on fibrillin-1, and that mesangial cell adhesion
and spreading on fibrillin-1 is RGD-dependent. Further,
fibrillin-1 facilitates the migration and proliferation of
cultivated mesangial cells. The fibrillin-1 fragments used for
coating in our experiments were confirmed to be fully
functional and equivalent to native polypeptides in a
previous study (Brinckmann J, El-Hallous E, Krieg T, Sakai
LY, Reinhardt DP. Absence of autoantibodies against correctly
folded recombinant protein in systemic scleroderma patients,
private communication). Moreover, we were able to show
that full-length fibrillin-115 and fragment rF6H were similarly
potent to promote adhesion and proliferation of mesangial
cells. Fibrillin-1 is present in the mesangial matrix of the
glomerulus and its expression is induced during the acute
phase of anti-Thy1.1 glomerulonephritis. The results of this
study support the hypothesis that fibrillin-1 contributes to
the regulation of mesangial cell adhesion, spreading, migra-
tion and proliferation. These mechanisms are involved in
the healing process of acute glomerulonephritis,12 following
the initial immunologic response with loss of glomerular
cells and formation of microaneurysms. Fibrillin-1 is more
abundant in the nephritic glomerulus and could thus
contribute to the regeneration of the glomerulus after
immunologic injury.
In contrast to the vascular system, where the predominant
role of fibrillin-1 is in tissue homeostasis,4,16 its role in the
glomerulus is much less clear. Patients with mutations in the
fibrillin-1 gene and mice underexpressing fibrillin-1 com-
monly suffer from alterations in the cardiovascular system
with aortic dilations and aneurysms.4 In the aorta, fibrillin-1,
together with elastin, forms elastic fibers.2 This association is
not detected in the glomerular mesangium, where elastin
expression or deposition is undetectable.5 Whether or not
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Figure 7 | Adhesion and proliferation of mesangial cells on full-
length fibrillin-1. (a) Mesangial cell adhesion to full-length fibrillin-1
(rFBN1, 10 mg/ml) and to FN (10 mg/ml) as a positive control is
significantly higher than to BSA, as measured 1 h after seeding.
(b) Mesangial cell proliferation on full-length fibrillin-1 is comparable
to the extent of proliferation on the positive control FN 24 h after
stimulation with 2% FCS. Results are representative of two similar
experiments (*Po0.05 versus BSA). Data are means7s.d.
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Figure 8 | Cell proliferation in glomerular cross sections of
kidneys from diabetic and nondiabetic mice underexpressing
fibrillin-1 (mgR/mgR) and their WT siblings. At 4 weeks of
diabetes, STZ leads to an induction of cell proliferation in the
glomerulus of WT mice. In the glomeruli of fibrillin-1-underexpressing
mice, the induction of cell proliferation following STZ treatment is
blunted (*Po0.05).
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fibrillin-1 contributes to the elasticity of the glomerular tuft
is not clear. Patients with Marfan syndrome displaying
mutations in the fibrillin-1 gene do not commonly suffer
from glomerular disease. Moreover, in mice underexpressing
fibrillin-1, no gross alterations either in glomerular archi-
tecture or in glomerular physiology were detected.17
A recent report describes a role for fibrillin-1 fragments
in regulating matrix metalloproteases (MMPs).18 Fibroblasts
grown on the RGD-containing fragment rF6H showed an
upregulation of MMP-1 and MMP-3. These results suggest
that fibrillin-1 – or at least its fragments – could be involved
in the regulation of matrix degradation, which is a feature of
many pathologic processes in the kidney.19 On the other
hand, MMPs may also directly influence the growth and
differentiation of mesangial cells.20 However, the expression
of the most common MMPs in the glomerulus, MMP-2, and
MMP-9, was not influenced by fibrillin-1 fragments in the
study of Booms et al.18 Thus, it is not clear if glomerular
fibrillin-1 would be able to increase MMP activity in the
mesangial matrix.
Fibrillin-1 was described as an adhesive matrix in different
cell types: dermal fibroblasts6,7,9 and vascular smooth muscle
cells8 in vitro attach to and spread on fibrillin-1. This is in
accordance with our findings for mesangial cells. We detected
a dose-dependent increase in mesangial cell adhesion on
rF6H, starting at a coating concentration of 3.8 mg/ml and
reaching a saturation level above 7.5 mg/ml. In a study by
Lorena et al.,21 however, liver fibroblasts showed an increase
in adhesion at low concentrations of rF6H and a decrease in
adhesion at higher concentrations. Fibrillin-1 contains one
single RGD sequence in its fourth eight-cysteine domain
(Figure 3). Previous studies have shown that a number of cell
lines including fibroblasts bind to fibrillin-1 fragments via the
RGD site.6,7,9 In addition, evidence exists for other non-RGD
cell interaction sites.6,9,22 Utilizing blocking RGD peptides,
we found that mesangial cell adhesion on rF6H was
completely RGD-dependent. All fibrillin-1-binding integrins
described to date are RGD-dependent integrins, namely avb3
and a5b1.6,7,9 These integrins are highly expressed and
present on the surface of mesangial cells. They are induced
during many glomerular diseases, including anti-Thy1.1
glomerulonephritis,23 and could thus contribute to the
adhesion of mesangial cells to fibrillin-1 in normal conditions
and during glomerular disease.
Whether or not fibrillin-1 has intrinsic properties to
mediate cell migration and proliferation was not known. For
this reason, we performed migration and proliferation
studies on the fibrillin-1 fragment rF6H. Both migration
and proliferation are promoted in mesangial cells attached to
rF6H. FN is a matrix protein, which is well known to
promote mesangial cell proliferation24 and migration25 and
was therefore used as a positive control. The fibrillin-1
fragment rF6H was similarly potent in inducing mesangial
cell migration and proliferation in vitro as compared to FN.
The contribution of fibrillin-1 to cell proliferation in vivo was
investigated in mice underexpressing fibrillin-1. Induction of
diabetic nephropathy with STZ leads to increased mesangial
cell proliferation.14 In mice underexpressing fibrillin-1, this
increase was not evident, arguing for an in vivo effect of
fibrillin-1 for cell proliferation. Taking into account that
mesangial cell migration and proliferation are important
mechanisms that help to reconstruct the glomerulus after
anti-Thy1.1 immunologic injury with loss of cells and the
structural integrity of the glomerulus,12 fibrillin-1 potentially
plays a protective role in this context and its upregulation
may contribute to the healing of the glomerulus. On the
other hand, proliferation of cells is one of the underlying
mechanisms of fibrotic alterations in many tissues, including
the kidney glomerulus.26 To elucidate the contribution of
fibrillin-1 to the resolution (or progression) of glomerular
disease will be the subject of further investigation.
MATERIALS AND METHODS
Induction of anti-Thy1.1 nephritis
All procedures performed on animals were carried out in accord-
ance with guidelines of the American Physiological Society and
were approved by the local government authorities. Male Sprague–-
Dawley rats (150–200 g) were obtained from Charles River Deutsch-
land (Sulzfeld, Germany). Anti-Thy1.1 nephritis was induced
by a single intravenous injection of 1 mg/kg body weight anti-
Thy1.1 antibody into the tail vein. Controls received solvent
only. The monoclonal antibody against Thy1.1 (ER4) was from
Antibody Solutions (Palo Alto, CA, USA). Five animals in each
group were killed on day 6 after induction of nephritis, and renal
tissue was obtained for further preparation. The kidneys were
decapsulated; one kidney was immediately snap-frozen in liquid
nitrogen for RNA extraction or preparation of cryostat sections;
the second kidney was used to isolate glomeruli by the sieving
technique at 41C for extraction of glomerular mRNA, as described
previously.11
Induction of type I diabetes in mice underexpressing
fibrillin-1
Heterozygous fibrillin-1-underexpressing mice (strain mgR) were a
generous gift from Dr F Ramirez (Hospital for Special Surgery, New
York, NY, USA), and were bred at our animal facilities.13 Fibrillin-1-
underexpressing mice were genotyped by PCR primers for fibrillin-1
(forward: 50-CTC CGT GGG ACC TAC AAA TG-30; reverse: 50-CCA
GGT GTG TTT CGA CAT TG-30) and neomycin (forward: 50-GTG
TTC CGG CTG TCA GCG CA-30; reverse: 50-GTC CTG ATA GCG
GTC CGC CA-30), detecting the native fibrillin-1 gene or the
introduced neomycin cassette, respectively. Female mice homo-
zygous for a defective fibrillin-1 gene and their WT (þ /þ )
littermates were used at an average weight of 20–25 g for induction
of diabetes. Diabetes was induced by intraperitoneal injection of
STZ (Sigma, Deisenhofen, Germany) (200 mg per kg of body
weight) dissolved in 0.1 M sodium citrate buffer (pH 4.5). After 2
days, blood was obtained from the tail vein and diabetes was
confirmed by measurement of blood glucose using a reflectance
meter (Glucometer Elite II, Bayer, Leverkusen, Germany). Only mice
with a consistent blood glucose level 4250 mg/dl were included in
the study. Blood glucose was followed daily (at 0800 h) for 5 weeks.
Then animals were killed and kidney tissue was fixed in methyl-
Carnoy solution (60% methanol, 30% chloroform, and 10% glacial
acetic acid). Tissues were dehydrated by bathing in increasing
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concentrations of methanol, followed by 100% iso-propanol. After
embedding in paraffin, 3 mm sections were cut with a Leitz SM 2000
R microtome (Leica Instruments, Nussloch, Germany).
Immunohistochemistry
Staining of cryostat sections was performed as described elsewhere.27
The primary rabbit antibody to fibrillin-128 was used at a dilution
1:500. CY3-labeled anti-rabbit immunoglobulin G (IgG) (DAKO
Diagnostica, Hamburg, Germany) was used as secondary antibody.
Stained sections were evaluated in a Leitz Aristoplan microscope
(Leica Instruments, Nussloch, Germany) as described previously.29
Glomerular fibrillin-1 staining was measured by Metaview in every
glomerulus per cross section of frozen kidney (25–42 cross sections
analyzed) and was expressed as percent of stained area per
glomerular tuft. For evaluation of interstitial fibrillin-1 staining,
the average area staining positive for fibrillin-1 in 10 high-power
cortical views per kidney section was calculated as a percentage of
the total cortical area.
Semiquantification of proliferating glomerular cells was per-
formed by immunohistochemistry, with a 1:50 diluted monoclonal
antibody detecting proliferating cell nuclear antigen (DAKO,
Hamburg, Germany), after deparaffinizing renal sections and
blocking endogenous peroxidase activity with 3% H2O2 in methanol
for 20 min at room temperature.30 As a negative control, we used
equimolar concentrations of preimmune goat or mouse IgG. Each
slide was counterstained with hematoxylin.
Isolation of mRNA and real-time PCR
To evaluate mRNA expression levels of fibrillin-1, total RNA was
obtained from the renal cortex by extraction with RNeasys Mini
columns (Quiagen, Hilden, Germany) and from isolated glomeruli
as described elsewhere.11 First-strand cDNA was synthesized with
TaqMan reverse transcription reagents (Applied Biosystems, Weiter-
stadt, Germany) using random hexamers as primers. The final RNA
concentration in the reaction mixture was adjusted to 0.1 ng/ml.
Reactions without Multiscribe reverse transcriptase were used as
negative controls for genomic DNA contamination. PCR was
performed with an ABI PRISM 7000 Sequence Detector System
and SYBR Green reagents (Applied Biosystems) according to the
manufacturer’s instructions. The relative amount of specific mRNA
was normalized with respect to 18S rRNA. Primers used for
amplification of 18S cDNA were forward 50TTGATTAAGTCCCTGC
CCTTTGT30 and reverse 50CGATCCGAGGGCCTCACTA30. For
amplification of the rat fibrillin-1 cDNA, the forward primer was
50TGCTCTGAAAGGACCCAATGT30 and the reverse primer was
50CGGGACAACAGTATGCGTTATAAC30. All samples were run in
triplicates.
Cultivation of rat mesangial cells
Mesangial cells were isolated from kidneys of Sprague–Dawley rats
by the sieving method, as described previously.31 Cultured mesangial
cells showed a typical vascular smooth muscle-like morphology,
positive immunostaining for smooth muscle a-actin and a8 integrin,
and negative staining for markers of other cell types. Mesangial cells
were grown in Dulbecco’s modified Eagle’s medium (PAA
Laboratories GmbH, Linz, Austria) containing 10% fetal calf serum
(FCS), 5 mg/ml insulin, 5 mg/ml plasmocin (TEBU, Frankfurt,
Germany) and 2 mM L-glutamine (Sigma, Deisenhofen, Germany)
in a 95% air–5% CO2 humidified atmosphere at 371C. Mesangial
cells were used for experiments in passages 5–15.
Coating of plates and chamber slides with matrix molecules
Two fibrillin-1 fragments were used for coating: rF6H containing
an RGD site and rF16 without an RGD site as depicted in Figure 3.32
In addition, correctly folded full-length recombinant fibrillin-1
was isolated as described,15 and was used for coating to further
validate the data obtained with fragment rF6H. Coating concentra-
tions and times were as indicated in the results. FN was used as a
positive control and BSA as a negative control. For spreading, focal
contact formation and proliferation experiments, 0.01% poly-L-
lysine was added to the matrices for coating to assure a similar
amount of cell adhesion on FN-, rF6H-, rF16-, and BSA-coated
plates.
Assays for adhesion, spreading and focal contact formation
An attachment assay was used based on the determination of the
number of adherent cells by measuring the activity of the lysosomal
enzyme hexosaminidase, as described by Gauer et al.33 Cells were
allowed to attach for 1 h. For inhibition of adhesion, cyclic RGD or
RAD peptides were obtained from Bachem, Switzerland, and used
for preincubation of cells in the concentrations indicated in the
results. Attachment on full-length fibrillin-1 was assessed after
seeding 5000 mesangial cells per chamber slide. After washing, and
staining with hematoxylin, adhered cells were counted in nine
medium-power views per chamber slide.
Spreading was determined in glass eight-well chamber slides 1 h
after seeding by counting hematoxylin–eosin-stained cells that were
attached and additionally clearly showed a cytoplasmatic area
surrounding the nucleus. Focal contacts were visualized by staining
cells with an antibody to vinculin (Sigma, Deissenhofen, Germany)
3 h after seeding as described.27
Determination of cell proliferation
Cell proliferation was estimated by using a BrdU incorporation assay
into cellular DNA with a BrdU Labeling and Detection Kit
(#1299964; Roche, Mannheim, Germany). Mesangial cells were
washed two times with phosphate-buffered saline and serum-starved
for 48 h in medium containing 0.1% FCS. After trypsinating and
washing, they were seeded into culture slides (Falcon Becton
Dickinson, Heidelberg, Germany), which had been coated with
matrix proteins and blocked with 2% BSA. After a 2 h resting time
for mesangial cells to attach to the matrix, mesangial cells were
incubated with bFGF (10 ng/ml) or medium containing 2% FCS and
BrdU for 48 h at 371C. Mesangial cells were then fixed with 70%
ethanol (50 mM glycine buffer, pH 2.0) and processed following the
manufacturer’s instructions. Incorporated BrdU was detected by
an alkaline phosphatase-conjugated secondary antibody reacting
with an NBT/X-phosphate substrate. Nuclei with a positive staining
for BrdU were counted in a Leitz Aristoplan microscope (Leica
Instruments, Nussloch, Germany).
Migration assay
A transmigration assay was applied as described recently.34
FluoroBlok Inserts (Falcon HTS, Becton Dickinson, Heidelberg,
Germany), containing a proprietary light-opaque PET membrane to
absorb visible light within the 490–700 nm range with 8 mm pores,
were coated with different matrix proteins and saturated in FCS-free
medium containing 1% BSA. Trypsinized mesangial cells were
washed twice, labeled with 50mg/ml DiI (Molecular Probes, Leiden,
The Netherlands), a vital lipophilic carbocyanine, for 10 min at 371C
and seeded into inserts in a volume of 150 ml at a density of
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1 106 cells/ml. The inserts were then incubated in 24 multiwell
plates (Becton Dickinson, Heidelberg, Germany), each well filled
with 700 ml medium containing 0.1% BSA for several hours.
Measurements were performed within 0 (starting point) and 48 h
incubation to observe transmigration. Transmigrated mesangial cells
were detected with a SPECTRAFluor fluorometer (Tecan).
Statistical analyses
Two-way analysis of variance, followed by the post hoc Newman–Keuls
test with adjustment for multiple comparisons, was used to test the
significance of differences between groups. A P-value o0.05 was
considered significant. The procedures were carried out using SPSS
software (SPSS Inc., Chicago, IL, USA). Values are displayed as
means7s.e.m. for evaluation of fibrillin-1 mRNA expression and tissue
protein expansion. Values are displayed as means7s.d. for cell assays.
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